Social Capital Suvretta Holdings Corp. II
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DNAB research report →
Price Chart
About the company
Formed in 2021 and headquartered in Henderson, Nevada, Social Capital Suvretta Holdings Corp. II currently conducts no significant business operations. Its principal aim is to achieve a business combination, such as a merger, acquisition of assets, or share exchange, with one or more companies operating in the biotechnology sector.
- CEO
- Chamath Palihapitiya
- IPO
- 2021
- HQ
- Henderson, NV, US
Get TickerSpark's AI analysis on DNAB
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $330.22M
- P/E
- 41.42
- PEG
- 0.00
- P/S
- 0.00
- P/B
- 1.08
- EV/EBITDA
- -382.61
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 2.59%
- ROIC
- -0.34%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-862,748
- Net Income
- $6.35M+0.0%
- EPS
- $0.25+0.0%
- OCF Growth
- +74.7%
- FCF Growth
- +74.7%
- 52W High
- $11.02
- 52W Low
- $9.73
- 50D MA
- $10.31
- 200D MA
- $10.13
- Beta
- 0.00
- RSI (14)
- 72
- Avg Volume
- 77.48K
No earnings-call transcripts are available for DNAB yet.
- Free Float
- 0.0%
- Shares Outstanding
- 31.89M
- Float Shares
- 0
of shares held by institutions
66 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Davidson Kempner Partners | 200.00K | ▲ 200.00K |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 29, 22 | Berman Robert | other | 0 |
| Sep 24, 21 | Nolan Sean P. | other | 0 |
| Aug 16, 21 | SCS Sponsor II LLC | sell | 75,000 |
| Jul 2, 21 | SCS Sponsor II LLC | other | 640,000 |
| Jun 29, 21 | SCS Sponsor II LLC | other | 6,295,000 |
| Jun 29, 21 | Srivastava Sapna | other | 30,000 |
| Jun 29, 21 | Ryans James | other | 0 |
| Jun 29, 21 | Katz Shoney | other | 0 |
| Oct 8, 12 | Marks Darren | sell | 47,700 |
| Oct 8, 12 | Leiner Melvin | sell | 100,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our DNAB coverage
Recent articles, reports, and earnings notes.
No research on DNAB yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate DNAB report →